Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Immunology Adaptive Immunity T Cells CD

Recombinant human CD45 protein (ab94517)

Recombinant human CD45 protein (ab94517)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: Baculovirus infected Sf9 cells
  • Purity: > 90% SDS-PAGE
  • Active: Yes
  • Suitable for: Functional Studies, WB, SDS-PAGE

You may also be interested in

Product image
Anti-CDw75 antibody [LN-1] (ab233965)
Alexa Fluor® 647 Anti-CD45RB antibody [MEM55] (ab187567)
Product image
Anti-CD19 antibody (ab99965)
Product image
APC Anti-CD27 antibody [LT27] (ab239293)

Description

  • Product name

    Recombinant human CD45 protein
    See all CD45 proteins and peptides
  • Biological activity

    The specific activity of ab94517 is 11,500 nmol phosphate released /min/mg
  • Purity

    > 90 % SDS-PAGE.
    >90% as determined by densitometry
  • Expression system

    Baculovirus infected Sf9 cells
  • Protein length

    Protein fragment
  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human
    • Amino acids

      604 to 1304

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 7.00
    Preservative: 1.02% Imidazole
    Constituents: 1.045% MOPS, 0.00174% PMSF, 0.00385% DTT, 25% Glycerol (glycerin, glycerine), 1.74% Sodium chloride

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

Images

  • Functional Studies - Recombinant human CD45 protein (ab94517)
    Functional Studies - Recombinant human CD45 protein (ab94517)
    ab94517 in a Sample Kinase Activity Plot.
  • SDS-PAGE - Recombinant human CD45 protein (ab94517)
    SDS-PAGE - Recombinant human CD45 protein (ab94517)
    ab94517 analysed by SDS PAGE at approximately 95kDa

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Recombinant human CD45 protein (ab94517)

  •  
  • Product image

    Recombinant Human CD45 protein (ab159286)

    Applications: ELISA, WB

  •  
  • Recombinant human CD45 protein (ab42584)

    Applications: FuncS

  •  
  • Product image

    Recombinant Human CD45 protein (Tagged) (ab236938)

    Applications: SDS-PAGE

  •  
  • Product image

    Recombinant Human CD45 protein (ab177717)

    Applications: MS, SDS-PAGE

  •  
  • Recombinant human CD45 protein (Fc Chimera Active) (ab214825)

    Applications: FuncS, SDS-PAGE

Clear all

Recently viewed products

  •  
  • Product image

    Anti-TOB2 antibody [EPR12588] - N-terminal (ab180514)

  •  
  • Product image

    Anti-Progesterone Receptor antibody - C-terminal (ab191138)

  •  
  • Product image

    Recombinant human IL2 Receptor beta/p75 protein (Active) (ab174003)

  •  
  • Product image

    Anti-Nucleophosmin (phospho T95) antibody [EPNCIR117] - BSA and Azide free (ab248502)

  •  
  • Product image

    Recombinant human SHP2 protein (Active) (ab268899)

  •  
  • Product image

    Human HSPB1 (Hsp27) knockout HeLa cell pellet (ab278998)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.